How do you discuss use of tamoxifen in your stage I breast cancer patients who are > 80 years old weighing in risk of VTE with benefit from adjuvant treatment?

Assuming aromatase inhibitor is not an option due to severe osteoporosis or if it is a man with breast cancer.

Answer from: Medical Oncologist at Academic Institution

The risk of both thrombotic events and endometrial cancer are age-dependent in general - much of this information is best interpreted from the prevention literature, where the numbers are larger, and the impacts of co-morbidities and concomitant medications are less. With tamoxifen use, both the abs...

Comments

Medical Oncologist at Johns Hopkins Health Care and Surgery Center
What do you do for your older 80+ male patients wi...

Medical Oncologist at University of Texas MD Anderson Cancer Center
For male breast cancer, in general, I prefer to us...

Please select the option that best describes you:

How do you discuss use of tamoxifen in your stage I breast cancer patients who are > 80 years old weighing in risk of VTE with benefit from adjuvant treatment?

Related Questions